Outpatient costs increased overall (USD 1,023.91±1,795.89 to 1,142.05±2,096.38, p<0.001), although this change did not reach statistical significance among non-exacerbators (p=0.155).
← all excerpts
Change in Exacerbation Rate of Asthma Patients before and after COVID-19 Infection.
1
0.1550
0.1550